Anticipating a possible unwelcome buyout offer, Fluor Corp (FLR-NYSE) has adopted a poison pill.
Alan Boeckmann, the contractor executive chairman, said in a statement that the measure "will protect stockholders from efforts to capitalize on recent market volatility as a result of the COVID-19 pandemic.”